The very first bellwether trial for TRT lawsuits ended in a mistrial which involved plaintiff Jeffrey Konrad whose allegation against AndroGel was that it caused his heart attack, thereby bringing a pause phase. But the $150 Million verdict to be paid as punitive damage by AbbVie to an Oregon man, under the claim of false marketing is a big news that brings a lot of hope to the Plaintiffs. Though the federal jury has not held AbbVie responsible for the alleged injury, this Chicago verdict can undoubtedly be considered as a strong signal to alert AbbVie and makes the battle turn positively towards the Plaintiffs. This verdict will now help thousands of TRT cases to move in the just and right direction. Neural IT has hands on experience in medical reviews and can be a potential partner for law firms looking forward to litigating TRTs.